Source: Annual Congress 2010 - COPD and asthma: models and human studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. L. Dumitriu, B. Gurzu, P. Plamadeala, L. Foia (Iasi, Romania). Airways renin angiotensin system activation during allergic lung disease. Eur Respir J 2010; 36: Suppl. 54, 1991

Member's Comments

No comment yet.

Related content which might interest you: Intrapulmonary renin angiotensin activation in antigen-induced airway hyperresponsiveness Source: Eur Respir J 2007; 30: Suppl. 51, 134s Year: 2007 Bronchial reactivity for histamine and serum angiotensin converting enzyme (sACE) activity in sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 669s Year: 2004 Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006 Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006 Allergic lung inflammation induces pulmonary vascular hyperresponsiveness Source: Eur Respir J 2006; 28: 370-377 Year: 2006 ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin Source: Eur Respir J 2008; 31: 363-371 Year: 2008 Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020 HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Ghrelin effects on local renin angiotensin from pulmonary vessels Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Autoimmunity  in airway inflammation and asthma Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease Year: 2017 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Inhibition of the renin-angiotensin system in severe COPD Source: Eur Respir J 2008; 32: 1128-1129 Year: 2008 Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010 The increased contractility of idiopathic pulmonary fibrosis lung fibroblasts is dependent on angiotensin signalling Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial Source: Eur Respir J 2006; 27: 972-979 Year: 2006 Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease Source: Eur Respir J 2007; 30: Suppl. 51, 60s Year: 2007 Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009 Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Source: Eur Respir J 2012; 39: 141-148 Year: 2012 Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis Source: Eur Respir J 2011; 39: 141-148 Year: 2012